193 related articles for article (PubMed ID: 27816118)
1. Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
Domanski M; Farkouh ME; Zak V; French J; Alexander JH; Bochenek A; Hamon M; Mahaffey K; Puskas J; Smith P; Shrader P; Fuster V
Am J Cardiol; 2016 Dec; 118(11):1655-1660. PubMed ID: 27816118
[TBL] [Abstract][Full Text] [Related]
2. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery.
Søraas CL; Friis C; Engebretsen KV; Sandvik L; Kjeldsen SE; Tønnessen T
Am Heart J; 2012 Nov; 164(5):779-85. PubMed ID: 23137510
[TBL] [Abstract][Full Text] [Related]
3. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.
Domanski MJ; Mahaffey K; Hasselblad V; Brener SJ; Smith PK; Hillis G; Engoren M; Alexander JH; Levy JH; Chaitman BR; Broderick S; Mack MJ; Pieper KS; Farkouh ME
JAMA; 2011 Feb; 305(6):585-91. PubMed ID: 21304084
[TBL] [Abstract][Full Text] [Related]
4. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
[TBL] [Abstract][Full Text] [Related]
6. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
7. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
[TBL] [Abstract][Full Text] [Related]
8. Indications for angiography subsequent to coronary artery bypass grafting.
Alter P; Vogt S; Herzum M; Irqsusi M; Rupp H; Maisch B; Moosdorf R
Am Heart J; 2005 Jun; 149(6):1082-90. PubMed ID: 15976792
[TBL] [Abstract][Full Text] [Related]
9. Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease.
Domanski MJ; Farkouh ME; Zak V; Feske S; Easton D; Weinberger J; Hamon M; Escobedo J; Shrader P; Siami FS; Fuster V
Am J Cardiol; 2015 May; 115(10):1382-8. PubMed ID: 25824543
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
[TBL] [Abstract][Full Text] [Related]
11. Nuclear imaging techniques in the assessment of myocardial perfusion and function after CABG: does it correlate with CK-MB elevation?
Kwinecki P; Jemielity M; Czepczyński R; Baszko A; Ruchała M; Sowiński J; Dyszkiewicz W
Nucl Med Rev Cent East Eur; 2003; 6(1):5-9. PubMed ID: 14600926
[TBL] [Abstract][Full Text] [Related]
12. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
Mahaffey KW; Roe MT; Kilaru R; Alexander JH; Van de Werf F; Califf RM; Simoons ML; Topol EJ; Harrington RA
Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
[TBL] [Abstract][Full Text] [Related]
13. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Cardiology; 2009; 113(2):122-31. PubMed ID: 19039220
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
[TBL] [Abstract][Full Text] [Related]
18. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).
Costa MA; Carere RG; Lichtenstein SV; Foley DP; de Valk V; Lindenboom W; Roose PC; van Geldorp TR; Macaya C; Castanon JL; Fernandez-Avilèz F; Gonzáles JH; Heyer G; Unger F; Serruys PW
Circulation; 2001 Nov; 104(22):2689-93. PubMed ID: 11723020
[TBL] [Abstract][Full Text] [Related]
19. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
[TBL] [Abstract][Full Text] [Related]
20. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation.
Blankenship JC; Islam MA; Wood GC; Iliadis EA
Catheter Cardiovasc Interv; 2004 Sep; 63(1):31-41. PubMed ID: 15343564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
